How Much Did Gene Matrix Raise?
Funding & Key Investors

Gene Matrix has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding accumulation of $150K, the organization continues to solidify its infrastructure for large-scale genetic analysis. The most recent financing round, totaling $150K, underscores the market confidence in the firm's ability to scale its proprietary diagnostic platforms within the competitive landscape of personalized medicine.

This strategic investment serves as a catalyst for the company to expand its operational footprint, transitioning from a high-growth innovator to a dominant player in the clinical genomics sector. By securing this backing, Gene Matrix is well-positioned to accelerate its research and development cycles, ensuring that its AI-driven diagnostic tools remain at the vanguard of modern healthcare delivery.

What is Gene Matrix?

Gene Matrix
Business ServicesResearch & DevelopmentHealthcare Services

Gene Matrix operates at the intersection of biotechnology and data science, specializing in the deployment of next-generation sequencing and advanced analytics. The company provides a comprehensive suite of genetic testing solutions designed to facilitate precision medicine, allowing healthcare providers to customize therapeutic interventions based on individual genetic markers. By prioritizing both technological efficacy and ethical data stewardship, Gene Matrix has established itself as a critical partner for clinical institutions seeking to integrate genomic insights into standard patient care protocols. Its market position is defined by a commitment to making complex genetic data both actionable and accessible, thereby bridging the gap between laboratory research and bedside application.

How much funding has Gene Matrix raised?

Gene Matrix has raised a total of $150K across 1 funding round:

2024

Debt

$150K

Debt (2024): $150K with participation from Huntington National Bank

Key Investors in Gene Matrix

Huntington National Bank

A prominent regional banking institution providing diversified financial services, including specialized debt financing and capital solutions for high-growth technology and healthcare enterprises.

What's next for Gene Matrix?

Looking ahead, the infusion of capital will likely be directed toward scaling the company's computational infrastructure and expanding its reach into international clinical markets. As Gene Matrix navigates this late-stage growth phase, the focus will shift toward optimizing its AI-driven analytics engine to handle larger datasets, thereby increasing the accuracy and speed of its diagnostic outputs. Furthermore, the firm is expected to pursue strategic partnerships with major healthcare networks to embed its testing solutions into routine diagnostic workflows. This expansion strategy is designed to solidify the company's competitive moat, ensuring that its proprietary methodologies become the industry standard for personalized treatment planning and long-term health management.

See full Gene Matrix company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject Management
Advertising NetworksBusiness ServicesRetailVitamins, Supplements & Health Stores
Advertising NetworksBusiness Services
Business ServicesHuman Resources Management Systems (HRMS)Project Management

Frequently Asked Questions Regarding Gene Matrix Financial Insights

What are the most recent funding rounds that Gene Matrix has completed, and what were the funding rounds?
Gene Matrix has recently completed 1 funding rounds: Debt on Sep 30, 2024.
What is the total amount of funding Gene Matrix has raised to date?
Gene Matrix has raised a total of $150K in funding to date.
How many funding rounds has Gene Matrix completed?
Gene Matrix has completed 1 funding rounds.
How much funding did Gene Matrix raise in its most recent funding round?
Gene Matrix raised $150K in its most recent funding round.
Who are the lead investors in Gene Matrix's latest funding round?
The lead investor in Gene Matrix's latest funding round was Huntington National Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Gene Matrix's history?
The largest funding round in Gene Matrix's history was $150K.
See more information about Gene Matrix